Journal
JOURNAL OF THE SOCIETY FOR INFORMATION DISPLAY
Volume 25, Issue 3, Pages 177-184Publisher
WILEY
DOI: 10.1002/jsid.543
Keywords
quantum dot light emitting devices (QLEDs); photomedicine; photodynamic therapy; photobiomodulation
Categories
Funding
- University of Central Florida [20080738]
- National Cancer Institute [UH2CA189901, R00CA155045]
- National Cancer Institute of the National Institutes of Health [R01 CA193610]
Ask authors/readers for more resources
While OLEDs have struggled to find a niche lighting application that can fully take advantage of their unique form factors as thin, flexible, lightweight and uniformly large-area luminaire, photomedical researchers have been in search of low-cost, effective illumination devices with such form factors that could facilitate widespread clinical applications of photodynamic therapy (PDT) or photobiomodulation (PBM). Although existing OLEDs with either fluorescent or phosphorescent emitters cannot achieve the required high power density at the right wavelength windows for photomedicine, the recently developed ultrabright and efficient deep red quantum dot light emitting devices (QLEDs) can nicely fit into this niche. Here, we report for the first time the in-vitro study to demonstrate that this QLED-based photomedical approach could increase cell metabolism over control systems for PBM and kill cancerous cells efficiently for PDT. The perspective of developing wavelength-specific, flexible QLEDs for two critical photomedical fields (wound repair and cancer treatment) will be presented with their potential impacts summarized. The work promises to generate flexible QLED-based light sources that could enable the widespread use and clinical acceptance of photomedical strategies including PDT and PBM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available